Fibrin as the mediator of tumor cell interaction with platelets
Ivan Tesakov(University Children's Hospital Tübingen), Anastasia N. Sveshnikova(Lomonosov Moscow State University), Anna E. Boldova(Center for Theoretical Problems of Physicochemical Pharmacology), Ekaterina V. Shamova(National Academy of Sciences of Belarus), Anna A Deputatova(Lomonosov Moscow State University), Екатерина Блинова(Sechenov University), A. A. Filkova(Center for Theoretical Problems of Physicochemical Pharmacology), Mikhail A. Panteleev(Center for Theoretical Problems of Physicochemical Pharmacology), A. D. Korneichuk(Center for Theoretical Problems of Physicochemical Pharmacology), А. G. Poleshko(Institute of Biophysics and Cell Engineering), Kristina A Mazova(Sechenov University), Viktoria A. Pakina(Sechenov University), Vladislav A Shumskiy(Institute of Biophysics and Cell Engineering), Anatoli U. Kokhan(National Academy of Sciences of Belarus), Yuliya D Korol(Institute of Biophysics and Cell Engineering), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology)
Cited by 3
Related Papers
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Effects of bacterial lipopolysaccharides on platelet function: inhibition of weak platelet activation
|Scientific Reports|2020|27
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14